Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, presenting promising improvements across many professional medical and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, much more reliable substitute fo